Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

NCT04875026 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: 5-fluorouracil 4% (Tolak)
DEVICE: Dexeryl

Sponsor

Pierre Fabre Medicament

Collaborators

[object Object]